Daejeon, South Korea

Jang Hwan Kim

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jang Hwan Kim: Innovator in Parkinson's Disease Research

Introduction

Jang Hwan Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of Parkinson's Disease research. His innovative methods have the potential to revolutionize treatment options for this debilitating condition.

Latest Patents

Jang Hwan Kim holds a patent for a method of preparation of induced dopaminergic progenitors using direct reprogramming. This invention involves inducing the expression of Oct4, Sox2, Klf4, and c-Myc genes in adult cells. The process allows for the direct reprogramming of these cells into induced dopaminergic neuronal progenitors (iDPs) by treating them with sonic hedgehog (SHH) and fibroblast growth factor 8 (FGF8). The iDPs can be utilized in cell therapy products and compositions aimed at treating or preventing Parkinson's Disease. Furthermore, his method includes preparing midbrain dopaminergic neurons and offers a novel approach for screening medicines for Parkinson's Disease.

Career Highlights

Jang Hwan Kim is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work has garnered attention for its innovative approach to utilizing patients' own somatic cells, which minimizes side effects and ethical concerns associated with conventional methods. His research has the potential to significantly improve the efficiency of differentiating neuronal progenitors into dopaminergic neurons.

Collaborations

Jang Hwan Kim has collaborated with notable colleagues, including Yee Sook Cho and Han Seop Kim. Their combined expertise has contributed to advancing research in the field of biotechnology and regenerative medicine.

Conclusion

Jang Hwan Kim's innovative work in the preparation of induced dopaminergic progenitors represents a significant advancement in the treatment of Parkinson's Disease. His contributions to biotechnology continue to inspire future research and development in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…